Search Results

There are 11117 results for: content related to: Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis

  1. Omeprazole: A Comprehensive Review

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 13, Issue 1, January-February 1993, Pages: 46–59, Firouzan Massoomi, John Savage and Christopher J. Destache

    Version of Record online : 19 JAN 2012, DOI: 10.1002/j.1875-9114.1993.tb02689.x

  2. Omeprazole: The first proton pump inhibitor

    Medicinal Research Reviews

    Volume 10, Issue 1, January/March 1990, Pages: 1–54, Per Lindberg, Arne Brändström, Björn Wallmark, Hillevi Mattsson, Leif Rikner and Kurt-Jürgen Hoffmann

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610100102

  3. You have free access to this content
    Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 8, August 2000, Pages: 963–978, C. A. M. Stedman and M. L. Barclay

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00788.x

  4. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety

    Alimentary Pharmacology & Therapeutics

    Volume 7, Issue 6, December 1993, Pages: 597–610, D. C. METZ, D. B. STRADER, M. ORBUCH, P. D. KOVIACK, K. M. FEIGENBAUM and R. T. JENSEN

    Version of Record online : 31 MAR 2007, DOI: 10.1111/j.1365-2036.1993.tb00140.x

  5. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 3, September 1999, Pages: 265–274, Takahisa Furuta, Kyoichi Ohashi, Kaoru Kobayashi, Izumi Iida, Hideo Yoshida, Naohito Shirai, Misako Takashima, Kazuhiro Kosuge, Hiroyuki Hanai, Kan Chiba, Takashi Ishizaki and Eizo Kaneko

    Version of Record online : 26 SEP 1999, DOI: 10.1016/S0009-9236(99)70034-2

  6. Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 368–377, Li Zhu, Anna Persson, Lisa Mahnke, Timothy Eley, Tong Li, Xiaohui Xu, Sangeeta Agarwala, Jeffrey Dragone and Richard Bertz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010367651

  7. Ethnic and genetic determinants of omeprazole disposition and effect

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 2, August 1996, Pages: 157–167, Yoseph Caraco, Per-Olaf Lagerstrom and Alastair J.J. Wood

    Version of Record online : 23 AUG 1996, DOI: 10.1016/S0009-9236(96)90131-9

  8. CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 5, May 1999, Pages: 552–561, Takahisa Furuta, Kyoichi Ohashi, Kazuhiro Kosuge, Xue-Jun Zhao, Misako Takashima, Masahiko Kimura, Masahiko Nishimoto, Hiroyuki Hanai, Eizo Kaneko and Takashi Ishizaki

    Version of Record online : 13 MAY 1999, DOI: 10.1016/S0009-9236(99)70075-5

  9. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours

    Biopharmaceutics & Drug Disposition

    Volume 27, Issue 8, November 2006, Pages: 361–370, Dae Y. Lee, Hyun S. Shin, Inchul Lee and Myung G. Lee

    Version of Record online : 8 AUG 2006, DOI: 10.1002/bdd.516

  10. Omeprazole Disposition in Children following Single-Dose Administration

    The Journal of Clinical Pharmacology

    Volume 43, Issue 8, August 2003, Pages: 840–848, Dr. Gregory L. Kearns, Dr. Tommy Andersson, Dr. Laura P. James, Dr. Andrea Gaedigk, Ms. Rebecca A. Kraynak, Dr. Susan M. Abdel-Rahman, Dr. Krishnaswami Ramabadran, Dr. John N. van den Anker and Pediatric Pharmacology Research Unit Network

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003256122

  11. Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 475–482, V Michaud, E Ogburn, N Thong, A O Aregbe, T C Quigg, D A Flockhart and Z Desta

    Version of Record online : 8 FEB 2012, DOI: 10.1038/clpt.2011.249

  12. Lack of Weight-Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 966–973, Dr. Myong-Jin Kim, Dr. Anne N. Nafziger, Dr. Yanhua Zhang, Dr. Edward M. Sellers, Dr. Andrea Gaedigk and Dr. Joseph S. Bertino Jr

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268910

  13. You have free access to this content
    Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.

    British Journal of Clinical Pharmacology

    Volume 37, Issue 6, June 1994, Pages: 597–604, T Andersson, JO Miners, ME Veronese and DJ Birkett

    Version of Record online : 5 JUL 2012, DOI: 10.1111/j.1365-2125.1994.tb04310.x

  14. You have free access to this content
    Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 6, June 2000, Pages: 651–668, Laine, Ahnen, Mcclain, Solcia and Walsh

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00768.x

  15. You have full text access to this OnlineOpen article
    The Effect of Orally Administered Ranitidine and Once-Daily or Twice-Daily Orally Administered Omeprazole on Intragastric pH in Cats

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 3, May/June 2015, Pages: 840–846, S. Šutalo, M. Ruetten, S. Hartnack, C.E. Reusch and P. H. Kook

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvim.12580

  16. Effect of oral omeprazole on basal and pentagastrin-stimulated gastric secretion in young female horses

    Equine Veterinary Journal

    Volume 24, Issue S13, August 1992, Pages: 80–83, F. M. Andrews, Christine C. Jenkins, J. T. Blackford, Donita L. Frazier, S.-G. Olovsson and H. Mattsson

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.2042-3306.1992.tb04793.x

  17. Omeprazole as a CYP2C19 Marker in Chinese Subjects: Assessment of Its Gene-Dose Effect and Intrasubject Variability

    The Journal of Clinical Pharmacology

    Volume 44, Issue 6, June 2004, Pages: 582–589, Dr. Ophelia Q. P. Yin, Dr. Brian Tomlinson, Dr. Albert H. L. Chow, Dr. Mary M. Y. Waye and Dr. Moses S. S. Chow

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004265702

  18. Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses

    Equine Veterinary Journal

    Volume 31, Issue S29, April 1999, Pages: 81–86, F. M. ANDREWS, R. L. SIFFERMAN, W. BERNARD, F. E. HUGHES, J. E. HOLSTE, C. P. DAURIO, R. ALVA and J. L. COX

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.2042-3306.1999.tb05176.x

  19. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin

    Clinical Pharmacology & Therapeutics

    Volume 62, Issue 4, October 1997, Pages: 384–391, Ylva Böttiger, Gunnel Tybring, Eva Götharson and Leif Bertilsson

    Version of Record online : 9 OCT 1997, DOI: 10.1016/S0009-9236(97)90116-8

  20. You have free access to this content
    Management of endoscopy-negative reflux disease: progress with short-term treatment

    Alimentary Pharmacology & Therapeutics

    Volume 11, Issue s2, December 1997, Pages: 87–92, Dr K. LAURITSEN

    Version of Record online : 25 AUG 2010, DOI: 10.1111/j.1365-2036.1997.tb00799.x